Director of AIDS Research Center to give Wistar Institute's 1999 Jonathan Lax Memorial Lecture

October 31, 1999

WHO: Bruce D. Walker, MD, Director, Partners AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, Boston

WHAT: 1999 Jonathan Lax Memorial Lecture, supported by Abbott Laboratories, Agouron Pharmaceuticals and Roche Laboratories, and presented by The Wistar Institute and Philadelphia FIGHT.
Dr. Walker's lecture is titled, "HIV Infection: Immune-Mediated Control."

WHEN: Wednesday, November 17, 1999

WHERE: 3:00 pm
The Joseph N. Grossman, MD Auditorium
The Wistar Institute
3601 Spruce Street
Philadelphia, PA 19104-4268

5:30- 9:00 pm
The Down Town Club
The Public Ledger Building, 11th Floor
150 South Independence Hall West
Philadelphia, PA 19103

Dr. Walker is a member of the American Association of Immunologists and the Infectious Diseases Society of America. He is Co-Chair of the Scientific Advisory Board of the Elizabeth Glaser Foundation, Chair of the National Institutes of Health AIDS ARRA Study Section and a member of the AIDS Clinical Trials Group at Massachusetts General Hospital. He also serves as Associate Editor for several journals, including AIDS and Journal of Immunology, and as Editor of Immunology Section, Los Alamos HIV Data Base.

Among the scientific awards he has received are the NIH Merit Award, the AIDS Research Amsterdam Endowed Chair for AIDS Research and the Doris Duke Distinguished Clinical Research Scientist Award for Excellence in 'Bench to Bedside' Research. Dr. Walker was cited by the Duke Foundation for leading an outstanding clinical research program that applies the latest basic medical research advances to the prevention, treatment and cure of AIDS.

Jonathan Lax was a Philadelphia businessman, inventor, teacher, AIDS activist and former president of Philadelphia FIGHT, a community-based clinical research network. He died of AIDS in 1996.

The Lax Lecture highlights the Wistar/Philadelphia FIGHT Collaborative Project, a research partnership formed to combine basic immunotherapy with community based research. It allows a patient population of over 4,000 individuals living with HIV/AIDS to participate in and learn about research through planned educational seminars.
The Wistar Institute, established in 1892, was the first independent medical research facility in the country. For more than 100 years, Wistar scientists have been making history and improving world health through their development of vaccines for diseases that include rabies, German measles, infantile gastroenteritis (rotavirus), and cytomegalovirus; discovery of molecules like interleukin-12, which are helping the immune system fight bacteria, parasites, viruses and cancer; and location of genes that contribute to the development of diseases like breast, lung and prostate cancer. Wistar is a National Cancer Institute Cancer Center.

The Wistar Institute

Related Aids Articles from Brightsurf:

Developing a new vaccination strategy against AIDS
Infection researchers from the German Primate Center (DPZ) -- Leibniz Institute for Primate Research have in cooperation with international colleagues tested a new vaccination strategy against the HIV-related simian immunodeficiency virus (SIV) in rhesus monkeys.

HIV-AIDS: Following your gut
Researchers find a way to reduce replication of the AIDS virus in the gastrointestinal tract.

A path toward ending AIDS in the US by 2025
Using prevention surveillance data to model rates of HIV incidence, prevalence and mortality, investigators at Brigham and Women's Hospital and Johns Hopkins Bloomberg School of Public Health set targets, specifically a decrease in new infections to 21,000 by 2020 and to 12,000 by 2025, that would mark a transition toward ending the HIV/AIDS epidemic.

What does it take for an AIDS virus to infect a person?
Researchers examined the characteristics of HIV-1 strains that were successful in traversing the genital mucosa that forms a boundary to entry by viruses and bacteria.

How AIDS conquered North America
A new technique that allowed researchers to analyze genetic material from serum samples of HIV patients taken before AIDS was known provides a glimpse of unprecedented detail into the beginnings of the AIDS epidemic in North America.

New research could help build better hearing aids
Scientists at Binghamton University, State University of New York want to improve sensor technology critical to billions of devices made every year.

NY State Department of Health AIDS Institute funds HIV/AIDS prevention in high-risk youth
NewYork-Presbyterian's Comprehensive Health Program and Project STAY, an initiative of the Harlem Heath Promotion Center (HHPC) at Columbia University's Mailman School of Public Health has received two grants totaling more than $3.75 million from the New York State Department of Health AIDS Institute for their continued efforts to prevent HIV/AIDS in at-risk youth.

A new way to nip AIDS in the bud
When new HIV particles bud from an infected cell, the enzyme protease activates to help the viruses infect more cells.

AIDS research prize for Warwick academic
A researcher at the University of Warwick has received international recognition for his contribution to AIDS research.

Insects inspire next generation of hearing aids
An insect-inspired microphone that can tackle the problem of locating sounds and eliminate background noise is set to revolutionize modern-day hearing aid systems.

Read More: Aids News and Aids Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to